Atlas Trials

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Clinical trial NCT04175600 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04175600
Sponsor
Actelion
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension, Pulmonary
Start date
2020-01-16
Primary completion
2024-10-11
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.